New Spring Catalog available - request your copy today
Burlingame, CA - March 12, 2012Featuring over 7000 antibodies, including 460+ new Rabbit Monoclonal Antibodies (RabMAbs). To request a copy, click here
Epitomics, Inc., an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research, diagnostic and therapeutic applications. The Company utilizes a unique and proprietary RabMAb® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays. Epitomics, Inc. is headquartered in Burlingame, California, and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China.